The MD Magazine Cardiology specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.



Latest CME


In Case You Missed It: ACC Scientific Sessions   2017 Wrap Up
THe ACC's meeting offered studies likelcc200y to impact clinical practice.
It’s a discussion that even the most seasoned physicians might struggle with—when is it time to talk end-of-life care? Ami Bhatt, MD, director of the Adult Congenital Heart Disease Program at Massachusetts General Hospital (MGH) explained both sides of the debate for patients with adult congenital heart disease.
Some women may have suffered with cardiovascular problems since birth while others don’t find out until pregnancy unmasks the condition. Doreen DeFaria Yeh, MD, discusses the importance of merging physicians from cardiology and obstetrics.
Compared with warfarin, are direct oral anticoagulants (DOACs), including apixaban, dabigatran, and rivaroxaban, better at reducing stroke and major bleeding risks in patients with non-valvular atrial fibrillation? Alpesh Amin, MD, professor of medicine at the University of California, Irvine breaks it down at ACC 2017 in Washington, District of Columbia.
NSAIDs may help a variety of painful conditions, but come with heart risks.
Steven Zelenkofske, DO, vice president of US Medical Affairs at AstraZeneca, talked with MD Magazine about the CVD-REAL study where researchers examined patients with type 2 diabetes taking the new class of diabetes drug, SGLT-2 inhibitors. Positive outcomes were reported with dapagliflozin, canagliflozin, and empagliflozin.
In patients with AFib, digoxin should not be a first-line drug.
Microbleeds in the brain appear to increase with cardiac procedures:Study.
Heart damage after non-cardiac surgery is usually missed. A test finds it.

Most Popular in Cardiology

Recent Published Journal


$vacMongoViewPlus$ $vAR$